Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery

     Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery

PR Newswire


INDIANAPOLIS, May 6, 2013 /PRNewswire/ --Eli Lilly and Company (NYSE:LLY)
today announced that John C. Lechleiter, Ph.D., chairman, president, and chief
executive officer, will undergo scheduled surgery for a dilated aorta on
Monday, May 13, 2013. This condition was found during unrelated testing and
has been asymptomatic. Lechleiter is expected to make a full recovery and
return to his duties later this summer.

In accordance with the company's bylaws, Derica W. Rice, executive vice
president, Global Services and chief financial officer, will assume the
additional role of acting chief executive officer during Lechleiter's surgery
and recuperation period. Ellen R. Marram, currently the board's lead
independent director, will serve as acting chairperson of the board of
directors. She was appointed as lead independent director in April 2012.

Rice, 48, has more than 22 years of service with Eli Lilly and Company,
including leadership roles in finance and general management. He became chief
financial officer in 2006 and assumed leadership of the company's global
services organization in 2010.

Marram, 66, is president of the Barnegat Group LLC, her business advisory
firm, and she is also the former CEO of two consumer products companies. She
has served on the Lilly board since 2002 and is also a member of the board of
directors of Ford Motor Company and The New York Times Company.

"I am grateful to be under the care of a world-class medical team located
right here in Indianapolis," said Lechleiter. "The board of directors and I
have the utmost confidence in Ellen, Derica, and our Lilly leadership team.
The company will be in very good hands during my leave. I look forward to
returning to work following my recovery."

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers-
through medicines and information- for some of the world's most urgent
medical needs. Additional information about Lilly is available at C-LLY

Refer to: (317) 433-9899, – Edward Sagebiel

(Logo: )

SOURCE Eli Lilly and Company

Press spacebar to pause and continue. Press esc to stop.